维普中文期刊产品整合服务
213篇 您的检索式:作者名="Hasselgren"
    题名 作者 年代 出处 被引量
1Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases:A review显示文摘Colorectal cancer is the third most common cancer in the Western world. Approximately half of patients will develop liver metastases, which is the most common cause of death. The only potentially curative treatment is surgical resection. However, many patients retain a to small future liver remnant(FLR) to allow for resection directly. There are therefore strategies todecrease the tumor with neoadjuvant chemotherapy and to increase the FLR. An accepted strategy to increase the FLR is portal vein occlusion(PVO). A concern with this strategy is that a large proportion of patients will never be operated because of progression during the interval between PVO and resection. ALPPS(associating liver partition and portal vein ligation for staged hepatectomy) is a new procedure with a high resection rate. A concern with this approach is the rather high frequency of complications and high mortality, compared to PVO. In this review, it is shown that with ALPPS the resection rate was 97.1% for CRLM and the mortality rate for all diagnoses was 9.6%. The mortality rate was likely lower for patients with CRLM, but some data were lacking in the reports. Due to the novelty of ALPPS, the indications and technique are not yet established but there are arguments for ALPPS in the context of CRLM and a small FLR.Kristina Hasselgren Per Sandstrom Bergthor Bjornsson 2015World Journal of Gastroenterology2015,21,15:16
2埃索美拉唑在十二指肠球部溃疡中根除幽门螺杆菌和愈合溃疡的疗效显示文摘Tulassay Z Kryszewski A Dite P Kleczkowski D Rudzinski J Bartuzi Z Hasselgren G Larko A Wrangstadh M 钟捷 2002中华消化杂志2002,22,10:11
3有症状的胃食管反流病中埃索美拉唑抑酸能力比奥美拉唑更强显示文摘Lind T Rydberg L Kyreback A Jonsson A Andersson T Hasselgren G Holmberg J Rohss K 钟捷 2002中华消化杂志2002,22,9:6
4含埃索美拉唑的一周三联治疗能有效根除幽门螺杆菌感染显示文摘Tulassay Z Kryszewski A Dite P Kleczkowski D Rudzinski J Bartuzi Z Hasselgren G Larko A Wrangstadh M 钟捷 2003中华消化杂志2003,23,2:5
5Muscle cachexia:current concepts of intracellular mechanisms and molecular regulation显示文摘Hasselgren Per-Olof M D 2001Ann Surg2001,233,:2
6How should liver hypertrophy be stimulated?A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)and portal vein embolization(PVE)with rescue possibility显示文摘Background:The role of associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)in comparison to portal vein embolization(PVE)is debated.The aim of this study was to compare successful resection rates(RR)with upfront ALPPS vs.PVE with rescue ALPPS on demand and to compare the hypertrophy of the liver between ALPPS and PVE plus subsequent rescue ALPPS.Methods:A retrospective analysis of all patients treated with PVE for colorectal liver metastasis(CRLM)or ALPPS(any diagnosis,rescue ALPPS included)at five Scandinavian university hospitals during the years 2013-2016 was conducted.A Chi-square test and a Mann-Whitney U test were used to assess the difference between the groups.A successful RR was defined as liver resection without a 90-day mortality.Results:A total of 189 patients were included.Successful RR was in 84.5%of the patients with ALPPS upfront and in 73.3%of the patients with PVE and rescue ALPPS on demand(P=0.080).The hypertrophy of the future liver remnants(FLRs)with ALPPS upfront was 71%(48-97%)compared to 96%(82-113%)after PVE and rescue ALPPS(P=0.010).Conclusions:Upfront ALPPS offers a somewhat higher successful RR than PVE with rescue ALPPS on demand.The sequential combination of PVE and ALPPS leads to a higher overall degree of hypertrophy than upfront ALPPS.Ernesto Sparrelid Kristina Hasselgren Bård Ingvald Røsok Peter Nørgaard Larsen Nicolai Aagaard Schultz Ulrik Carling Eva Fallentin Stefan Gilg Per Sandström Gert Lindell Bergthor Björnsson 2021Hepatobiliary Surgery and Nutrition2021,10,1:2
7Catabolic response to stress and potential benefits of nutrition support显示文摘WRAY CJ JOSHUA MV HASSELGREN P 2002Nutrifion2002,18,:1
8Effect of esomeprazole 40mg vs omeprazole 40mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease 显示文摘Rohss K Hasselgren G Hedenstrom H 2002Dig Dis Sci2002,47,5:1
9Drug interaction studies with esomeprazole, the ( S ) -isomer of omeprazole 显示文摘Andersson T Hassan-AlinM Hasselgren G 2001Clin pharacokinet2001,40,:1
10The effect of AUC and Cmax of esomeprazole on acid secretion and intragastric PH显示文摘Junghard O Hassan-Alin M Hasselgren G 2000Gastroenterology2000,118,:1
11Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis显示文摘 Pedersen P Sax HC 1988Arch Surg1988,123,8:1
12Endodontic treatment of experimental root perforation in dog teeth 显示文摘Petersson K Hasselgren G Tronstad L 1985Endod Traumat1985,1,:1
13Bone grafting unnecessary in the treatment of enchondroma in the hand 显示文摘Hasselgren G Forssblad P Jomvall A 1991J Hand Surg Am1991,16,1:1
14Pharmacokinetic studies with esomeprazole,the (S) isomeRof omeprazole显示文摘Andersson T Hassan-Alin M Hasselgren G 2001Clin Pharmacokinet2001,40,:1
15Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation 显示文摘Hasselgren PO Fischer JE 2001Area Surg2001,233,1:1
16Insulin-like growth factor-1 blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways显示文摘Li BG Hasselgren PO Fang CH 2004The Journal of burn care & rehabilitation2004,25,:1
17The effete of auc and cmax of esomeprazole on acid secretion and intragastric PH显示文摘Junghard o hassan Alin M hasselgren G 2000Gastroenterology2000,118,:1
18Corticosteroids and muscle wasting:role of transcription factors,nuclear cofactors,and hyperacetylation显示文摘Hasselgren PO Alamdari N Aversa Z 0,,04:1
19Pathologic interactions in pulpal and periodontal tissues 显示文摘Zehnder M Gold SI Hasselgren G 2002J Clin Periodontal2002,29,8:1
20Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort显示文摘VON KOBYLETZKI L B BORNEHAG C G HASSELGREN M 2012BMC Dermatol2012,12,:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费